Professor, Oncologic Sciences, USF-Morsani
Oncology
Dr. Julie A. Kish, MD
|
|
Give Review
Julie Kish is an expert in the field of Oncology. She researched medicine at Wayne State University School of Medicine. Wayne State University School of Medicine has a rank of 63 in research and a 85 in primary care Julie Kish has written publications. She has 51 publications published with PubMed. The lastest publication is: 'Continuous-infusion 5-fluorouracil and cisplatin for advanced/recurrent transitional cell cancer of the bladder: a Southwest Oncology Group trial.' Julie Kish accepts all Medicare patients.
Publications
- Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal Cancer.
- Risk factors for percutaneous endoscopic gastrostomy tube placement during chemoradiotherapy for oropharyngeal Cancer.
- Intensity-modulated radiation therapy as primary treatment for oropharyngeal squamous Cell carcinoma.
- An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous Cell head and...
- Effect of prophylactic fluconazole on oral mucositis and candidiasis during radiation therapy for head-and-neck Cancer.
- Phase II clinical evaluation of AZQ in renal Cell carcinoma.
- Cis-platinum and 5-fluorouracil as induction therapy for advanced head and neck Cancer.
- Aclacinomycin. Phase II evaluation in advanced squamous Carcinoma of the head and neck.
- Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of...
- 5-Fluorouracil cardiotoxicity: left ventricular dysfunction and effect of coronary vasodilators.
- A randomized, double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induc...
- Vindesine in head and neck Cancer. A Southwest Oncology Group Phase II pilot study.
- The clinical syndrome of 5-fluorouracil cardiotoxicity.
- Phase II evaluation of diaziquone in recurrent head and neck Cancer.
- Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous Cell carcinoma of the head and neck.
- The incidence and significance of thromboembolic complications in patients with high-grade Gliomas.
- Response rate and toxicity with aziridinylbenzoquinone in patients with recurrent Gliomas. A progress report.
- The role of induction chemotherapy in advanced head and neck Cancer: the Wayne State University experience.
- Solid tumor preparation for clinical application of flow cytometry.
- Superior clinical response and survival rates with initial bolus of cisplatin and 120 hour infusion of 5-fluorouracil before definitive therapy for locally advanced he...
- Combined modality therapy utilizing a cisplatin combination for effective chemotherapy in patients with previously untreated head and neck Cancer.
- Platinum analogs in recurrent and advanced head and neck Cancer: a Southwest Oncology Group and Wayne State University Study.
- Continuous-infusion 5-fluorouracil and cisplatin for advanced/recurrent transitional cell Cancer of the bladder: a Southwest Oncology Group trial.
- Feasibility trial of postoperative radiotherapy and cisplatin followed by three courses of 5-FU and cisplatin in patients with resected head and neck Cancer: a Southwe...
- The Wayne State University experience with adjuvant chemotherapy of head and neck Cancer.
- Phase II evaluation of 4'deoxydoxorubicin in advanced renal Cell carcinoma.
- Chemotherapy for paranasal sinus Carcinoma. A 10-year experience at Wayne State University.
- Improved complete response rate and survival in advanced head and neck Cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin.
- The activity of a single-agent 5-fluorouracil infusion in advanced and recurrent head and neck Cancer.
- ExCellent response to cis-platinum-based chemotherapy in patients with recurrent or previously untreated advanced nasopharyngeal carcinoma.
- Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid Cancer of the head and neck.
- The impact of conventional morphologic analysis on response rates and survival in patients with advanced head and neck Cancers treated initially with cisplatin-contain...
- Proto-chemotherapy in advanced head and neck Cancer.
- Cellular DNA content parameters in untreated and recurrent squamous cell Cancers of the head and neck.
- Phase II study of continuous infusion recombinant gamma interferon in renal Carcinoma. A Southwest Oncology Group study.
- A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous Cell carcinoma of the head and neck.
- Evaluation of high-dose cisplatin and 5-FU infusion as initial therapy in advanced head and neck Cancer.
- A phase II trial of interferon-alpha and 5-fluorouracil in patients with advanced renal Cell carcinoma. A Southwest Oncology Group study.
- Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell Cancers o...
- Phase II evaluation of amonafide in renal Cell carcinoma. A Southwest Oncology Group study.
- Achievement of superior survival for histologically negative versus histologically positive clinically complete responders to cisplatin combination in patients with lo...
- Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-Cell carcinoma of the head and neck: a ...
- Metastatic squamous Cell carcinoma of an unknown primary localized to the neck. Advantages of an aggressive treatment.
- The role of infection in the morbidity and mortality of patients with head and neck Cancer undergoing multimodality therapy.
- The correlation of specific variables of tumor differentiation with response rate and survival in patients with advanced head and neck Cancer treated with induction ch...
- An intensive, five course, alternating combination chemotherapy induction regimen used in patients with advanced, unresectable head and neck Cancer.
- A phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for Adult patients with malignant gliom...
- Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-Cell carcinoma of the head and neck.
- Evaluation of fludarabine phosphate in Malignant melanoma. A Southwest Oncology Group study.
- Evaluation of low dose continuous infusion 5-fluorouracil in patients with advanced and recurrent renal Cell carcinoma. A Southwest Oncology Group Study.
Schools
Wayne State Univ Som
Wayne State University
Wayne State University Affiliated Hospitals
Wayne State University In Detroit Michigan
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Adult Development Disorders
- Anal and Rectal Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Wayne State University School of Medicine
Hospital
-
Tampa General Hospital -
H. Lee Moffitt Cancer Center and Research Institute
Drug Facts
| NPI NUMBER | 1790774701 | |
| NPPES Provider LastName | KISH | |
| NPPES Provider FirstName | JULIE | |
| NPPES Provider ZIPCode | 336129416 | |
| NPPES Provider State | FL | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 547.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 30.0 | |
| Percent Opioid Claims | 5.48 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1790774701 |
| Last Name Of The Provider | KISH |
| First Name Of The Provider | JULIE |
| View All |
Similar Doctors
|
Dr. Julio Lautersztain, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Amber L. Flaherty, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joyson J. Karakunnel, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Claudio Anasetti, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Bryan McIver, MD |
|
Dr. William S. Dalton, MD
This Doctor is OpenDoctor Recommended.
|